Market News (Page 1) - TendieTensor

Market News Page 1 of 179 • 4,459 articles

Hedge Fund Buys 622,500 Knowles Shares as Stock Outperforms S&P 500 — Should You?

The Motley Fool • Jonathan Ponciano

Hedge Fund Buys 622,500 Knowles Shares as Stock Outperforms S&P 500 — Should You?

12/07/2025 01:30 PM • Harvey Partners initiated a $14.5 million stake in Knowles Corporation, acquiring 622,500 shares in Q3. The company, which specializes in micro-acoustic components for various industries, has outperformed the S&P 500 with a 20% stock gain over the past year.

HPQ - Mentioned as a technology partner contributing to IGEL's ecosystem
KN - Strong Q3 performance with 7% revenue growth, expanding gross margins, positive earnings, healthy backlog, and projected 6% organic revenue growth

#hedge fund #micro-acoustic #audio components #OEM #electronics

Why One Fund Just Put $23.5 Million Into Champion Homes Despite an 18% Stock Slide

The Motley Fool • Jonathan Ponciano

Why One Fund Just Put $23.5 Million Into Champion Homes Despite an 18% Stock Slide

12/07/2025 12:30 PM • Tensile Capital Management invested $23.5 million in Champion Homes, acquiring 308,162 shares despite the stock's 18% annual decline, indicating potential long-term growth opportunity in factory-built housing.

SKY - Despite stock's recent underperformance, the company shows solid fundamentals with 11% net sales growth, expanded gross margins, and strong operational execution

#factory-built housing #institutional investment #housing market #manufactured homes

WPP INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that WPP plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc

WPP INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that WPP plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

12/07/2025 12:00 PM • A class action lawsuit has been filed against WPP plc alleging false and misleading statements about its media operations, market performance, and competitive challenges during the period of February 22, 2024 to July 8, 2025.

WPP - The lawsuit alleges the company made false statements, concealed material adverse facts about its media operations, was losing market share, and misled investors about its business prospects and performance

#class action #securities lawsuit #investor alert #market share #financial disclosure

MRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Marex Group plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc

MRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Marex Group plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

12/07/2025 12:00 PM • A class action lawsuit has been filed against Marex Group plc alleging false financial statements and undisclosed conflicts of interest during the period of May 16, 2024 to August 5, 2025.

MRX - Lawsuit alleges multiple serious financial irregularities including selling over-the-counter financial products to itself, creating conflicts of interest, and having unreliable financial statements that misled investors

#class action #securities lawsuit #financial misconduct #investor alert

Evaluating VRT Stock's Actual Performance

The Motley Fool • John Bromels

Evaluating VRT Stock's Actual Performance

12/07/2025 11:31 AM • Vertiv, a data infrastructure company, has experienced significant stock volatility due to AI investments. Despite challenges in 2022, the stock has outperformed the S&P 500 with impressive three-year returns of 1,110%.

VRT - Stock has generated market-crushing returns of 1,110% over three years, recovered from 2022 losses, and benefited from AI and data center infrastructure investments

#AI #data centers #stock performance #infrastructure

Why One Investor Just Doubled Down on Clearwater Analytics Stock with a $45 Million Position

The Motley Fool • Jonathan Ponciano

Why One Investor Just Doubled Down on Clearwater Analytics Stock with a $45 Million Position

12/07/2025 11:30 AM • Tensile Capital Management increased its Clearwater Analytics stake by 1.2 million shares in Q3, bringing its total position to 2.5 million shares valued at $45.5 million, despite the stock's 27.5% decline over the past year.

CWAN - Strong fundamentals with 77% revenue growth, 84% adjusted EBITDA increase, 98% revenue retention, and $49 million operational cash flow suggest potential future growth despite current stock price challenges

#investment #stock #SaaS #financial software #data infrastructure

Hyper Converged Infrastructure Market Set for Strong Expansion to USD 84.72 Billion by 2033, Driven by Rising Hybrid Cloud Adoption and Demand for Simplified IT Management | SNS Insider

GlobeNewswire Inc. • Sns Insider

Hyper Converged Infrastructure Market Set for Strong Expansion to USD 84.72 Billion by 2033, Driven by Rising Hybrid Cloud Adoption and Demand for Simplified IT Management | SNS Insider

12/07/2025 10:00 AM • The Hyper Converged Infrastructure Market is projected to grow from USD 16.16 billion in 2025 to USD 84.72 billion by 2033, with a 23.01% CAGR, driven by hybrid cloud adoption and simplified IT management needs.

NTNX - Mentioned as a key player with strong HCI solutions and partnership developments

#Hyper Converged Infrastructure #Cloud Computing #IT Management #Digital Transformation

Consumer Tech News (Dec 1-5): Trump Says He's Back in Elon Musk's Social Circle, U.S. Suspends China MSS Sanctions & More

Benzinga • Lekha Gupta

Consumer Tech News (Dec 1-5): Trump Says He's Back in Elon Musk's Social Circle, U.S. Suspends China MSS Sanctions & More

12/07/2025 09:46 AM • The week's tech news highlighted developments in AI, electric vehicles, semiconductors, and tech leadership, with notable updates from major tech companies and discussions around AI regulation and competition.

TSLA - Mentioned in context of Trump's social relationship with Elon Musk, no significant business developments reported

#AI #electric vehicles #semiconductors #tech leadership #quantum computing

Decision Intelligence Market to Reach USD 74.23 Billion by 2033, Owing to Rising Adoption of AI-Enabled Data-Driven Decision-Making | SNS Insider

GlobeNewswire Inc. • Sns Insider

Decision Intelligence Market to Reach USD 74.23 Billion by 2033, Owing to Rising Adoption of AI-Enabled Data-Driven Decision-Making | SNS Insider

12/07/2025 09:45 AM • The decision intelligence market is projected to grow from $18.08 billion in 2025 to $74.23 billion by 2033, driven by increasing AI and machine learning adoption, cloud-based solutions, and demand for real-time strategic insights across industries.

REGMY - Collaborated on successful clinical trial and submitted Biologics License Application for telitacicept in IgA Nephropathy
IBM - Highlighted as a leading company investing in market-leading product offerings and driving innovation in decision intelligence technologies

#decision intelligence #AI #machine learning #cloud computing #data analytics

Autism Spectrum Disorder Market to Reach USD 4.07 Billion by 2033, Driven by Rising Awareness, Early Diagnosis & Advances in Personalized Therapeutics | SNS Insider

GlobeNewswire Inc. • Sns Insider

Autism Spectrum Disorder Market to Reach USD 4.07 Billion by 2033, Driven by Rising Awareness, Early Diagnosis & Advances in Personalized Therapeutics | SNS Insider

12/07/2025 08:43 AM • The global Autism Spectrum Disorder market is projected to grow from USD 2.06 billion in 2025 to USD 4.07 billion by 2033, driven by increasing awareness, early diagnosis, and advances in personalized therapeutics, with a CAGR of 8.89%.

REGMY - Collaborated on successful clinical trial and submitted Biologics License Application for telitacicept in IgA Nephropathy
RHHBY - Initiated collaborative research program to identify genetic markers for ASD subtypes, aiming to enhance diagnostic precision

#Autism Spectrum Disorder #Market Growth #Therapeutics #Early Diagnosis #Personalized Treatment

US Stormwater Management Market Size Worth USD 15.05 Billion by 2033 | SNS Insider

GlobeNewswire Inc. • Sns Insider

US Stormwater Management Market Size Worth USD 15.05 Billion by 2033 | SNS Insider

12/07/2025 08:00 AM • The U.S. Stormwater Management Market is projected to grow from $8.25 billion in 2025 to $15.05 billion by 2033, driven by environmental regulations, infrastructure upgrades, urbanization, and increasing adoption of green stormwater solutions.

WMS - Actively participating in market research and survey about flooding concerns, indicating proactive market engagement

#stormwater management #green infrastructure #urban design #environmental sustainability #infrastructure

ALX Oncology Announces Positive Results from Ongoing Investigator-Sponsored Phase 2 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with Indolent B-cell Non-Hodgkin Lymphoma, at ASH Annual Meeting

GlobeNewswire Inc. • Alx Oncology Holdings Inc.

ALX Oncology Announces Positive Results from Ongoing Investigator-Sponsored Phase 2 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with Indolent B-cell Non-Hodgkin Lymphoma, at ASH Annual Meeting

12/07/2025 08:00 AM • ALX Oncology reported impressive results from a Phase 2 trial combining evorpacept with rituximab and lenalidomide in treating indolent non-Hodgkin lymphoma, achieving a 92% complete response rate and 100% overall response rate.

ALXO - Demonstrated strong clinical trial results with high complete response rates, promising efficacy of their lead therapeutic candidate evorpacept, and positive outlook for future development

#evorpacept #non-Hodgkin lymphoma #clinical trial #immunotherapy #CD47

Energy Trading & Risk Management Market Size to Hit $61.59 Billion by 2033 | Report by SNS Insider

GlobeNewswire Inc. • Sns Insider

Energy Trading & Risk Management Market Size to Hit $61.59 Billion by 2033 | Report by SNS Insider

12/07/2025 08:00 AM • The ETRM market is projected to grow from USD 41.06 billion in 2025 to USD 61.59 billion by 2033, driven by cloud-based solutions, renewable energy expansion, and increasing market volatility in energy trading.

SAP - Mentioned as a market player without specific details about recent innovations or performance

#energy trading #risk management #cloud computing #renewable energy #market analytics

$Genmab Presents Pivotal Phase 3 Data from EPCORE® FL-1 Trial Demonstrating Clinical Benefit of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide (R2) in Patients with Relapsed or Refractory Follicular Lymphoma$

GlobeNewswire Inc. • Genmab A/S

Genmab Presents Pivotal Phase 3 Data from EPCORE® FL-1 Trial Demonstrating Clinical Benefit of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide (R2) in Patients with Relapsed or Refractory Follicular Lymphoma

12/07/2025 07:50 AM • Genmab announced positive Phase 3 trial results for EPKINLY, demonstrating significant clinical benefits in treating relapsed or refractory follicular lymphoma when combined with rituximab and lenalidomide, reducing disease progression risk by 79% and achieving a 95% overall response rate.

GMAB - Successful Phase 3 trial results, FDA approval, significant clinical efficacy demonstrated in treating follicular lymphoma

#follicular lymphoma #bispecific antibody #cancer treatment #clinical trial #immunotherapy

Pixalate’s Q3 2025 Report Uncovers 1,248 APAC-Registered Mobile Apps Across Apple App & Google Play Stores Violating COPPA, Impacting 117 Million Child-App Users in USA

GlobeNewswire Inc. • Pixalate

Pixalate’s Q3 2025 Report Uncovers 1,248 APAC-Registered Mobile Apps Across Apple App & Google Play Stores Violating COPPA, Impacting 117 Million Child-App Users in USA

12/07/2025 12:00 AM • Pixalate's research reveals 1,248 APAC-registered mobile apps likely violating COPPA privacy regulations, potentially impacting 117 million child app users in the USA, with significant data transmission and privacy policy deficiencies.

GOOG - Ad Exchange appeared in 45% of apps identified as likely non-compliant under COPPA

#COPPA #children's privacy #mobile apps #data privacy #app stores

CRMT Investor News: If You Have Suffered Losses in America’s Car-Mart, Inc. (NASDAQ: CRMT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

GlobeNewswire Inc. • Rosen Law Firm

CRMT Investor News: If You Have Suffered Losses in America’s Car-Mart, Inc. (NASDAQ: CRMT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

12/06/2025 05:34 PM • Rosen Law Firm is investigating potential securities claims for America's Car-Mart shareholders after the company reported a significant first-quarter loss and stock price decline.

NVO - Mentioned in comparison to other obesity treatments, but no direct impact on their performance from this specific trial
CRMT - Stock dropped 18.2% after reporting a first-quarter loss of 69 cents per share, compared to a 15 cents per share loss in the previous year, indicating deteriorating financial performance

#securities claims #investor losses #class action #stock performance

DXCM DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages DexCom, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – DXCM

GlobeNewswire Inc. • Rosen Law Firm

DXCM DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages DexCom, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – DXCM

12/06/2025 04:39 PM • Rosen Law Firm alerts DexCom investors about a securities class action lawsuit alleging unauthorized design changes to glucose monitoring systems that potentially compromised device reliability and user safety.

DXCM - Lawsuit claims the company made unauthorized design changes to G6 and G7 continuous glucose monitoring systems, potentially creating health risks and exposing the company to regulatory scrutiny, legal challenges, and reputational damage

#securities #class action #FDA #glucose monitoring #investor rights

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP

GlobeNewswire Inc. • Rosen Law Firm

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP

12/06/2025 03:51 PM • Rosen Law Firm is investigating potential securities claims for Inspire Medical Systems investors who purchased stock between August 6, 2024 and August 4, 2025, alleging misrepresentation about their sleep apnea device Inspire V's market demand and launch readiness.

INSP - The lawsuit suggests the company misrepresented key facts about their product's market demand and launch preparedness, potentially misleading investors and causing financial damages

#securities class action #investor rights #sleep apnea device #stock lawsuit

ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

GlobeNewswire Inc. • Rosen Law Firm

ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

12/06/2025 02:55 PM • Rosen Law Firm is investigating potential securities claims for Alvotech shareholders following an FDA Complete Response Letter for their Biologics License Application, which caused a significant stock price drop.

SOXX - Semiconductor stocks tracked by the ETF dropped 7.4% for the week
ALVO - The company received a Complete Response Letter from FDA for AVT05, resulting in a 34% stock price drop on November 3, 2025, and an additional 4% decline on November 4, 2025. The FDA noted unresolved deficiencies in their manufacturing facility inspection, indicating significant regulatory challenges.

#securities claims #FDA #Biologics License Application #stock price #investor losses

THE EFFICIENCY PARADOX: 5 Market Anomalies Trading Below Reality

GlobeNewswire Inc. • Usa News Group

THE EFFICIENCY PARADOX: 5 Market Anomalies Trading Below Reality

12/06/2025 01:51 PM • Market intelligence report highlighting five undervalued companies across biotech, AI, defense, gold exploration, and medical technology sectors, suggesting significant potential for valuation growth due to technological innovations and strategic positioning.

AMD - Experienced significant stock price decline as part of broader AI stock selloff
ONCY - Developing innovative cancer immunotherapy with promising Phase 3 trial design, FDA alignment, and partnerships with major pharmaceutical companies

#biotech #AI #defense technology #gold exploration #medical diagnostics #small-cap investing

AGL Investor News: If You Have Suffered Losses in agilon health, inc. (NYSE: AGL), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

GlobeNewswire Inc. • Rosen Law Firm

AGL Investor News: If You Have Suffered Losses in agilon health, inc. (NYSE: AGL), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

12/06/2025 01:36 PM • Rosen Law Firm is investigating potential securities claims for agilon health shareholders after the company suspended its 2025 financial guidance, causing a 51.5% stock price drop on August 5, 2025.

PLTR - Dropped as part of the broader technology and AI stock market decline
AGL - Company suspended full-year financial guidance, acknowledged more severe industry headwinds than previously expected, and experienced a significant 51.5% stock price decline

#securities claims #investor losses #financial guidance #stock price drop

$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger—WBD, TRUE, CMA, and FITB

GlobeNewswire Inc. • Juan Monteverde

$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger—WBD, TRUE, CMA, and FITB

12/06/2025 01:00 PM • Law firm Monteverde & Associates is investigating several corporate mergers and acquisitions, including transactions involving Warner Bros. Discovery, trueCar, Comerica, and Fifth Third Bancorp.

WBD - Potential sale to Netflix with defined share and cash exchange terms

#mergers #acquisitions #shareholder #class action #investigation

$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger—TBHC, BLFY, SOUL, and SNCR

GlobeNewswire Inc. • Juan Monteverde

$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger—TBHC, BLFY, SOUL, and SNCR

12/06/2025 01:00 PM • Law firm Monteverde & Associates is investigating several corporate mergers involving technology, banking, and acquisition companies, offering shareholders potential legal recourse.

TBHC - Proposed sale to Bed Bath & Beyond with defined stock exchange ratio

#merger #shareholder #class action #investigation

ATYR Lawsuit: Hagens Berman Urges aTyr Pharma Investors to Act by Dec. 8 Deadline in Suit Over Trial Failure

GlobeNewswire Inc. • Reed Kathrein

ATYR Lawsuit: Hagens Berman Urges aTyr Pharma Investors to Act by Dec. 8 Deadline in Suit Over Trial Failure

12/06/2025 12:58 PM • Hagens Berman is pursuing a securities class action lawsuit against aTyr Pharma after its flagship drug trial failed, causing an 83% stock price collapse. The lawsuit alleges the company misrepresented the efficacy of its drug Efzofitimod and concealed material adverse facts about its performance.

ATYR - Stock collapsed 83% after drug trial failure, facing lawsuit alleging misleading investors about drug efficacy, potential securities law violations

#securities lawsuit #drug trial #pharmaceutical #investor rights #clinical trial

TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

GlobeNewswire Inc. • Rosen Law Firm

TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

12/06/2025 12:53 PM • Rosen Law Firm is investigating potential securities claims for Tandem Diabetes Care shareholders following a voluntary medical device correction that caused a significant stock price drop.

TNDM - Company issued a voluntary medical device correction for t:slim X2 insulin pumps that triggered a 19.9% stock price decline, indicating potential product reliability issues and investor concern

#securities claim #medical device #stock drop #investor losses